An official website of the United States government
Here’s how you know
Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A
lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including naloxone/Narcan. The Data Profile also presents the training of first responders, community organization staff and other individuals to administer the reversal medications and provide other support services.
This report presents data from DAWN using national estimates and trends of opioid-involved emergency department (ED) visits in the United States, including those involving prescription opioids, fentanyl, heroin, and opioids not otherwise specified.
This resource document briefly explains the three different types of CCBHCs and the pathways for becoming each. It is designed for the use of potential CCBHCs, CCBHC clinic leadership and staff, and state government officials, to support their engagement with the CCBHC model.
This comprehensive resource is designed to help communities expand access to lifesaving medications like naloxone to reduce overdose fatalities. The toolkit provides actionable guidance for community leaders, public health professionals, and other partners to create effective overdose prevention and response strategies to improve local overdose reduction outcomes.
This report highlights the Substance Abuse and Mental Health Services Administration’s (SAMHSA) commitment to advancing behavioral health recovery across the nation. It underscores the importance of reducing barriers to recovery supports and driving systemic change through enhanced intra-agency coordination. By aligning efforts with recovery principles and valuing the expertise of individuals with lived and living experience, their families, and caregivers, SAMHSA aims to promote greater access to mental health and substance use recovery services. This report details the OR’s strategic partnerships with various stakeholders, working to ensure that all individuals can pursue recovery and achieve lives marked by home, health, community, and purpose.
A guidance document from the Wellness in the Workplace Summit that convened both federal and non-federal partners to review innovative approaches for identifying and creating employment opportunities for people in or seeking recovery from substance use and/or mental health conditions. The issue brief is intended for use as a guide by businesses and state and local governments to implement the identified best practices of recovery ready workplaces and wellness initiatives and includes information on what is a recovery ready workplace, where to start, case examples, and additional resources to learn more.
A toolkit that offers critical analysis across harm reduction and recovery, recommends facts and guidance for advancing partnerships between harm reduction and recovery providers, and helps to inform policies that may impact local, state, and federal funding for harm reduction and recovery.
SAMHSA’s new National Guidance on Essential Specialty Substance Use Disorder (SUD) Care articulates a core or essential set of services for adults with SUD that should be available at any specialty SUD treatment facility in the United States.
SAMHSA’s updated National Behavioral Health Crisis Care Guidance is comprised of three documents: 2025 National Guidelines for a Behavioral Health Coordinated System of Crisis Care; Model Definitions for Behavioral Health Emergency, Crisis, and Crisis-Related Services and a draft Mobile Crisis Team Services: An Implementation Toolkit.
SAMHSA has issued two new papers on integration of behavioral health care in specialty care settings such as oncology and gastroenterology clinics. One paper focuses on care for adults and the other pediatric populations. The two papers discuss examples of integrated care models, key components of integrated care models and examples. The goal of these papers is to help ensure patients in these specialty care settings have access to behavioral health care.
